Literature DB >> 30660333

Modern Management of ST-Segment Elevation Myocardial Infarction.

Jennifer Frampton, James T Devries, Terrence D Welch, Bernard J Gersh.   

Abstract

Disruption of intracoronary plaque with thrombus formation resulting in severe or total occlusion of the culprit coronary artery provides the pathophysiologic foundation for ST-segment elevation myocardial infarction (STEMI). Management of STEMI focuses on timely restoration of coronary blood flow along with antithrombotic therapies and secondary prevention strategies. The purpose of this review is to discuss the epidemiology, pathophysiology, and diagnosis of STEMI. In addition, the review will focus on guideline-directed therapy for these patients and review potential associated complications.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Year:  2018        PMID： 30660333     DOI： 10.1016/j.cpcardiol.2018.08.005

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN： 0146-2806            Impact factor:   5.200


  7 in total

1.  Protection of CAPE-pNO2 Against Chronic Myocardial Ischemia by the TGF-Β1/Galectin-3 Pathway In Vivo and In Vitro.

Authors:  Qin Wan; Liwen Zhang; Qidi Zhou; Yanmin Han; Zhubo Li; Boheng Li
Journal:  Inflammation       Date:  2021-11-24       Impact factor: 4.092

2.  Relationship between Admission Electrolyte Level and Short-term Prognosis of Patients with Acute ST-segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention.

Authors:  Yaping Ren; Zhijie Yue; Xuewen Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-09       Impact factor: 2.629

3.  Brown adipose tissue prevents glucose intolerance and cardiac remodeling in high-fat-fed mice after a mild myocardial infarction.

Authors:  Carmem Peres Valgas da Silva; Vikram K Shettigar; Lisa A Baer; Eaman Abay; Kendra L Madaris; Mikayla R Mehling; Diego Hernandez-Saavedra; Kelsey M Pinckard; Nickolai P Seculov; Mark T Ziolo; Kristin I Stanford
Journal:  Int J Obes (Lond)       Date:  2021-10-29       Impact factor: 5.095

4.  Effect of Tirofiban Injection on vascular endothelial function, cardiac function and inflammatory cytokines in patients with acute myocardial infarction after emergency Percutaneous Coronary Intervention.

Authors:  Shi-Xin Kang; Xiao-Min Meng; Jing Li
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

5.  Protective Effects and Mechanisms of Recombinant Human Glutathione Peroxidase 4 on Isoproterenol-Induced Myocardial Ischemia Injury.

Authors:  Chang Liu; Bozhao Li; Qi Yan; Shaopeng Niu; Yiding Zhao; Changhao Xiong; Tianjiao Zhang; Jingyan Wei
Journal:  Oxid Med Cell Longev       Date:  2021-09-07       Impact factor: 6.543

6.  Comparison of Efficacy and Safety of Recombinant Human Prourokinase and Alteplase in the Treatment of STEMI and Analysis of Influencing Factors of Efficacy.

Authors:  Yizhou Liu; Yulin Yang; Ying Li; Xiaoqing Peng
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-06       Impact factor: 2.629

7.  Improved Cardiac Function and Attenuated Inflammatory Response by Additional Administration of Tirofiban during PCI for ST-Segment Elevation Myocardial Infarction Patients.

Authors:  Jing Zhang; Guomin Ding
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-16       Impact factor: 2.629
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.